Oracle and Buck Institute Partner on Federal Aging Research Initiative

Apple has announced its most advanced health and fitness experience yet, introducing the Apple Watch Series 12 and Apple Watch Ultra 4 with a new Health Sensing System that delivers the most accurate heart rate sensing in a wearable, along with a redesigned Health app powered by Apple Intelligence. The new watches measure heart rate every five seconds and HRV as often as every five minutes, 24 times more frequently, and introduce a readiness score from 0 to 10 with recommendations like Recover or Go For It. The redesigned Health app, coming later this year with iOS 27, adds an Insights tab and a Longevity tab featuring Health Age, which compares users' metrics to their chronological age. Users can also schedule and purchase lab tests covering over 50 biomarkers for $119 at approximately 2,000 Quest Diagnostics locations in the U.S., and new movement assessments use the iPhone camera and Apple Watch for at-home evaluations. The watches also support perimenopause and menopause tracking, and watchOS 27 will be available starting September 14 for Apple Watch Series 9 or later, Apple Watch SE 3, and Apple Watch Ultra 2 or later.

The Trade Policy and Strategy Office revealed that health care and anti-aging trends will push global consumer spending on medical goods and services to as high as 6.7 trillion US dollars by 2040, more than doubling compared with the past 15 years. In 2025, Thailand's retail value in the herbal product group was 1.3575 billion US dollars, ranking 11th in the world, and is expected to reach 1.8364 billion US dollars by 2030. Consumers are willing to pay at least 20 percent more if products have scientific test results to support them. The Trade Policy and Strategy Office proposed four urgent strategies: upgrading agricultural extracts to the medical level, penetrating everyday products and personalized nutrition, integrating technology for personalized health care, and linking the service ecosystem with health tourism under the Agri-Wellness Synergy concept to transform Thailand's agricultural sector into a health economy.

Business Alignment Public Company Limited, or BIZ, reported second-quarter 2026 net profit of 85.18 million baht, up 87.75 percent from 45.37 million baht in the same period last year. Total revenue reached 542.57 million baht, a 29.51 percent increase from 418.94 million baht, driven mainly by the delivery of radiation therapy machines and medical equipment according to plan. CEO Sompong Chuenkittiyanont said the company will press ahead with expanding BIZGENES, a personalized DNA analysis platform, to capture the trend of preventive and personalized healthcare, while broadening service channels across hospitals, clinics, and general consumers. The company also plans to bid for new projects and negotiate with partners to support future projects, expressing confidence that full-year 2026 performance will grow as targeted, backed by its order backlog and rising after-sales maintenance revenue.

Merz Aesthetics and the National Nanotechnology Center under NSTDA have signed a research collaboration on Aesthetic Longevity to elevate Thailand's beauty industry into a global hub. The goal is to transition from being a user of foreign innovations to a standard-setter and knowledge creator, supporting Thailand's health economy market valued at 1.4 trillion baht under the Thailand Global Health Hub 2025 to 2034 strategy. This partnership will leverage Nanotec's cellular-level research platforms, such as telomere analysis and epigenetic clock, together with Merz's technologies to generate scientific evidence that meets the needs of modern consumers who seek in-depth information before deciding on beauty services. Both parties view evidence-driven approaches as the key to market competition, enabling physicians to plan personalized treatments with greater precision and safety.

The Animal Longevity Summit has announced its inaugural two-day scientific conference, taking place October 1–2, 2026, in Toronto. The event will bring together leading experts in geroscience, veterinary medicine, biotechnology, and aging research to explore how the biology of aging can be measured, slowed, and translated into longer, healthier lives, beginning with animals. The summit arrives as landmark initiatives such as the Dog Aging Project and a growing number of veterinary clinical trials generate the first large-scale datasets on interventions to improve healthspan and longevity in companion animals. The conference program will feature eight scientific tracks covering canine longevity, comparative biology of aging, biomarkers, longevity interventions, veterinary geroscience, cross-species translation to human health, and emerging research from early-career scientists. The inaugural speaker lineup includes Dr. Matt Kaeberlein of the Dog Aging Project, Dr. Vera Gorbunova of the University of Rochester, Dr. Aubrey de Grey of the LEV Foundation, Dr. Varun Dwaraka of TruDiagnostic, Liz Parrish of BioViva, and Dr. Raghav Sehgal of Yale, with additional speakers to be announced. Industry participation is also expected, with Genflow Biosciences confirming it will present new findings from its SLAB study investigating gene therapy in aged beagles.